Table 4.
IPAa Identified Eight Candidate Biomarkers Differentially Expressed Between pCRb and non-pCR Patients
Gene | Chromosome | Association | Difference | p value | Q-Bound |
---|---|---|---|---|---|
ENO2 | 12 | Prognosis, efficacy | 29 | <0.0004 | 0.0964927 |
TPI1 | 12 | Unspecified application | 29 | <0.0004 | 0.0964927 |
GAPDH | 12 | Disease progression | 28 | <0.0004 | 0.1793397 |
CD4 | 12 | Efficacy | 28 | <0.0004 | 0.1793397 |
ING4 | 12 | Diagnosis | 28 | <0.0004 | 0.1793397 |
CD27 | 12 | Unspecified application | 28 | <0.0004 | 0.1793397 |
TNFRSF1A | 12 | Prognosis | 28 | <0.0004 | 0.1793397 |
SCG5 | 15 | Diagnosis | 33 | <0.003 | 0.2018752 |
Ingenuity pathway analysis.
Pathologic complete response.